Imhm.Bk

IMHM.BK's capital structure is characterized by a high debt-to-equity ratio of 1.99, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 0.4, suggesting limited short-term liquidity to cover immediate liabilities. The operating cash flow of 146,925,500 THB is positive, but the free cash flow is negative at -163,836,120 THB, indicating that the company is not generating sufficient cash to fund its operations and capital expenditures without external financing.

Profitability metrics for IMHM.BK are concerning, with a return on equity of -0.3476 and a return on assets of -0.0898, both significantly below the industry median. These figures suggest that the company is not effectively utilizing its equity and assets to generate profits, which is a critical issue for a company in the healthcare sector where operational efficiency is paramount.

The company's revenue is primarily concentrated in the pharmaceuticals segment, with no disclosed geographic diversification. This concentration increases the risk associated with market fluctuations in the pharmaceuticals sector. The lack of geographic diversification may also limit the company's ability to mitigate regional economic downturns or regulatory changes.

IMHM.BK's growth trajectory is mixed, with a negative operating income of -126,152,620 THB and a net income of -188,694,540 THB. The company's capital expenditure of -25,094,450 THB indicates ongoing investment in infrastructure, but the negative net income suggests that these investments are not yet yielding positive returns. The outlook for the current fiscal year is uncertain, with no clear indication of improvement in the near term.

Risk factors for IMHM.BK include a high debt load, with long-term debt of 1,082,261,890 THB, and a negative net cash position after subtracting total debt. The company's dilution potential is low, but the negative free cash flow and high debt-to-equity ratio increase the risk of future dilution if the company needs to raise additional capital. The risk assessment indicates a medium liquidity risk, primarily due to the company's inability to cover its short-term liabilities with its current assets.

Recent events and filings for IMHM.BK have not been disclosed in the available data. However, the company's financial performance and risk profile suggest that it may need to address its liquidity and profitability issues to sustain long-term growth. The lack of recent events or transcripts may indicate a period of relative stability, but the financial metrics suggest otherwise.